Global Epithelial Ovarian Cancer Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 96 pages | ID: G0D8E8AE66FCEN
QYResearch

Abstracts

This report focuses on the global Epithelial Ovarian Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epithelial Ovarian Cancer Treatment development in North America, Europe and Asia-Pacific.

The key players covered in this study

• C. H. Boehringer Sohn
• Takeda
• Amgen
• ImmunoGen
• AbbVie
• Bayer
• Synta Pharmaceuticals
• Prima BioMed
• Oasmia Pharmaceutical
• Glycotope

Market segment by Type, the product can be split into

• Surgery
• Chemotherapy
• Radiation Therapy

Market segment by Application, split into

• Hospitals
• Ambulatory Surgical Center
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Epithelial Ovarian Cancer Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Epithelial Ovarian Cancer Treatment development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Epithelial Ovarian Cancer Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Epithelial Ovarian Cancer Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Epithelial Ovarian Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Surgery
  1.4.3 Chemotherapy
  1.4.4 Radiation Therapy
1.5 Market by Application
  1.5.1 Global Epithelial Ovarian Cancer Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Ambulatory Surgical Center
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Epithelial Ovarian Cancer Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Epithelial Ovarian Cancer Treatment Industry
    1.6.1.1 Epithelial Ovarian Cancer Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Epithelial Ovarian Cancer Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Epithelial Ovarian Cancer Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Epithelial Ovarian Cancer Treatment Market Perspective (2015-2026)
2.2 Epithelial Ovarian Cancer Treatment Growth Trends by Regions
  2.2.1 Epithelial Ovarian Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Epithelial Ovarian Cancer Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Epithelial Ovarian Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Epithelial Ovarian Cancer Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Epithelial Ovarian Cancer Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Epithelial Ovarian Cancer Treatment Players by Market Size
  3.1.1 Global Top Epithelial Ovarian Cancer Treatment Players by Revenue (2015-2020)
  3.1.2 Global Epithelial Ovarian Cancer Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Epithelial Ovarian Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Epithelial Ovarian Cancer Treatment Market Concentration Ratio
  3.2.1 Global Epithelial Ovarian Cancer Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Epithelial Ovarian Cancer Treatment Revenue in 2019
3.3 Epithelial Ovarian Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Epithelial Ovarian Cancer Treatment Product Solution and Service
3.5 Date of Enter into Epithelial Ovarian Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Epithelial Ovarian Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Epithelial Ovarian Cancer Treatment Forecasted Market Size by Type (2021-2026)

5 EPITHELIAL OVARIAN CANCER TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Epithelial Ovarian Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Epithelial Ovarian Cancer Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Epithelial Ovarian Cancer Treatment Market Size (2015-2020)
6.2 Epithelial Ovarian Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Epithelial Ovarian Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Epithelial Ovarian Cancer Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Epithelial Ovarian Cancer Treatment Market Size (2015-2020)
7.2 Epithelial Ovarian Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Epithelial Ovarian Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Epithelial Ovarian Cancer Treatment Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size (2015-2020)
8.2 Epithelial Ovarian Cancer Treatment Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Type (2015-2020)
8.4 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 C. H. Boehringer Sohn
  9.1.1 C. H. Boehringer Sohn Company Details
  9.1.2 C. H. Boehringer Sohn Business Overview and Its Total Revenue
  9.1.3 C. H. Boehringer Sohn Epithelial Ovarian Cancer Treatment Introduction
  9.1.4 C. H. Boehringer Sohn Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020))
  9.1.5 C. H. Boehringer Sohn Recent Development
9.2 Takeda
  9.2.1 Takeda Company Details
  9.2.2 Takeda Business Overview and Its Total Revenue
  9.2.3 Takeda Epithelial Ovarian Cancer Treatment Introduction
  9.2.4 Takeda Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020)
  9.2.5 Takeda Recent Development
9.3 Amgen
  9.3.1 Amgen Company Details
  9.3.2 Amgen Business Overview and Its Total Revenue
  9.3.3 Amgen Epithelial Ovarian Cancer Treatment Introduction
  9.3.4 Amgen Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020)
  9.3.5 Amgen Recent Development
9.4 ImmunoGen
  9.4.1 ImmunoGen Company Details
  9.4.2 ImmunoGen Business Overview and Its Total Revenue
  9.4.3 ImmunoGen Epithelial Ovarian Cancer Treatment Introduction
  9.4.4 ImmunoGen Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020)
  9.4.5 ImmunoGen Recent Development
9.5 AbbVie
  9.5.1 AbbVie Company Details
  9.5.2 AbbVie Business Overview and Its Total Revenue
  9.5.3 AbbVie Epithelial Ovarian Cancer Treatment Introduction
  9.5.4 AbbVie Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020)
  9.5.5 AbbVie Recent Development
9.6 Bayer
  9.6.1 Bayer Company Details
  9.6.2 Bayer Business Overview and Its Total Revenue
  9.6.3 Bayer Epithelial Ovarian Cancer Treatment Introduction
  9.6.4 Bayer Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020)
  9.6.5 Bayer Recent Development
9.7 Synta Pharmaceuticals
  9.7.1 Synta Pharmaceuticals Company Details
  9.7.2 Synta Pharmaceuticals Business Overview and Its Total Revenue
  9.7.3 Synta Pharmaceuticals Epithelial Ovarian Cancer Treatment Introduction
  9.7.4 Synta Pharmaceuticals Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020)
  9.7.5 Synta Pharmaceuticals Recent Development
9.8 Prima BioMed
  9.8.1 Prima BioMed Company Details
  9.8.2 Prima BioMed Business Overview and Its Total Revenue
  9.8.3 Prima BioMed Epithelial Ovarian Cancer Treatment Introduction
  9.8.4 Prima BioMed Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020)
  9.8.5 Prima BioMed Recent Development
9.9 Oasmia Pharmaceutical
  9.9.1 Oasmia Pharmaceutical Company Details
  9.9.2 Oasmia Pharmaceutical Business Overview and Its Total Revenue
  9.9.3 Oasmia Pharmaceutical Epithelial Ovarian Cancer Treatment Introduction
  9.9.4 Oasmia Pharmaceutical Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020)
  9.9.5 Oasmia Pharmaceutical Recent Development
9.10 Glycotope
  9.10.1 Glycotope Company Details
  9.10.2 Glycotope Business Overview and Its Total Revenue
  9.10.3 Glycotope Epithelial Ovarian Cancer Treatment Introduction
  9.10.4 Glycotope Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020)
  9.10.5 Glycotope Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Epithelial Ovarian Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Epithelial Ovarian Cancer Treatment Revenue
Table 3. Ranking of Global Top Epithelial Ovarian Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Epithelial Ovarian Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiation Therapy
Table 8. COVID-19 Impact Global Market: (Four Epithelial Ovarian Cancer Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Epithelial Ovarian Cancer Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Epithelial Ovarian Cancer Treatment Players to Combat Covid-19 Impact
Table 13. Global Epithelial Ovarian Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Epithelial Ovarian Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Epithelial Ovarian Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Epithelial Ovarian Cancer Treatment Market Share by Regions (2015-2020)
Table 17. Global Epithelial Ovarian Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Epithelial Ovarian Cancer Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Epithelial Ovarian Cancer Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Epithelial Ovarian Cancer Treatment Players
Table 24. Global Epithelial Ovarian Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Epithelial Ovarian Cancer Treatment Market Share by Players (2015-2020)
Table 26. Global Top Epithelial Ovarian Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epithelial Ovarian Cancer Treatment as of 2019)
Table 27. Global Epithelial Ovarian Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Epithelial Ovarian Cancer Treatment Product Solution and Service
Table 30. Date of Enter into Epithelial Ovarian Cancer Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Epithelial Ovarian Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Epithelial Ovarian Cancer Treatment Market Size Share by Type (2015-2020)
Table 34. Global Epithelial Ovarian Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Epithelial Ovarian Cancer Treatment Market Size Share by Application (2015-2020)
Table 36. Global Epithelial Ovarian Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Epithelial Ovarian Cancer Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Epithelial Ovarian Cancer Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Epithelial Ovarian Cancer Treatment Market Share (2019-2020)
Table 40. North America Epithelial Ovarian Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Epithelial Ovarian Cancer Treatment Market Share by Type (2015-2020)
Table 42. North America Epithelial Ovarian Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Epithelial Ovarian Cancer Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Epithelial Ovarian Cancer Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Epithelial Ovarian Cancer Treatment Market Share (2019-2020)
Table 46. Europe Epithelial Ovarian Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Epithelial Ovarian Cancer Treatment Market Share by Type (2015-2020)
Table 48. Europe Epithelial Ovarian Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Epithelial Ovarian Cancer Treatment Market Share by Application (2015-2020)
Table 50. Asia-Pacific Key Players Epithelial Ovarian Cancer Treatment Revenue (2019-2020) (Million US$)
Table 51. Asia-Pacific Key Players Epithelial Ovarian Cancer Treatment Market Share (2019-2020)
Table 52. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Share by Type (2015-2020)
Table 54. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Share by Application (2015-2020)
Table 56. C. H. Boehringer Sohn Company Details
Table 57. C. H. Boehringer Sohn Business Overview
Table 58. C. H. Boehringer Sohn Product
Table 59. C. H. Boehringer Sohn Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020) (Million US$)
Table 60. C. H. Boehringer Sohn Recent Development
Table 61. Takeda Company Details
Table 62. Takeda Business Overview
Table 63. Takeda Product
Table 64. Takeda Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020) (Million US$)
Table 65. Takeda Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Product
Table 69. Amgen Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020) (Million US$)
Table 70. Amgen Recent Development
Table 71. ImmunoGen Company Details
Table 72. ImmunoGen Business Overview
Table 73. ImmunoGen Product
Table 74. ImmunoGen Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020) (Million US$)
Table 75. ImmunoGen Recent Development
Table 76. AbbVie Company Details
Table 77. AbbVie Business Overview
Table 78. AbbVie Product
Table 79. AbbVie Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020) (Million US$)
Table 80. AbbVie Recent Development
Table 81. Bayer Company Details
Table 82. Bayer Business Overview
Table 83. Bayer Product
Table 84. Bayer Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020) (Million US$)
Table 85. Bayer Recent Development
Table 86. Synta Pharmaceuticals Company Details
Table 87. Synta Pharmaceuticals Business Overview
Table 88. Synta Pharmaceuticals Product
Table 89. Synta Pharmaceuticals Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020) (Million US$)
Table 90. Synta Pharmaceuticals Recent Development
Table 91. Prima BioMed Business Overview
Table 92. Prima BioMed Product
Table 93. Prima BioMed Company Details
Table 94. Prima BioMed Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020) (Million US$)
Table 95. Prima BioMed Recent Development
Table 96. Oasmia Pharmaceutical Company Details
Table 97. Oasmia Pharmaceutical Business Overview
Table 98. Oasmia Pharmaceutical Product
Table 99. Oasmia Pharmaceutical Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020) (Million US$)
Table 100. Oasmia Pharmaceutical Recent Development
Table 101. Glycotope Company Details
Table 102. Glycotope Business Overview
Table 103. Glycotope Product
Table 104. Glycotope Revenue in Epithelial Ovarian Cancer Treatment Business (2015-2020) (Million US$)
Table 105. Glycotope Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Epithelial Ovarian Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Therapy Features
Figure 5. Global Epithelial Ovarian Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Center Case Studies
Figure 8. Others Case Studies
Figure 9. Epithelial Ovarian Cancer Treatment Report Years Considered
Figure 10. Global Epithelial Ovarian Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Epithelial Ovarian Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Epithelial Ovarian Cancer Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Epithelial Ovarian Cancer Treatment Market Share by Players in 2019
Figure 15. Global Top Epithelial Ovarian Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epithelial Ovarian Cancer Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Epithelial Ovarian Cancer Treatment Revenue in 2019
Figure 17. North America Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. C. H. Boehringer Sohn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. C. H. Boehringer Sohn Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2015-2020)
Figure 22. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Takeda Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2015-2020)
Figure 24. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Amgen Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2015-2020)
Figure 26. ImmunoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. ImmunoGen Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2015-2020)
Figure 28. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. AbbVie Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2015-2020)
Figure 30. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bayer Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2015-2020)
Figure 32. Synta Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Synta Pharmaceuticals Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2015-2020)
Figure 34. Prima BioMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Prima BioMed Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2015-2020)
Figure 36. Oasmia Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Oasmia Pharmaceutical Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2015-2020)
Figure 38. Glycotope Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Glycotope Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed